Can a simple blood test spot lymphoma earlier?
NCT ID NCT07750886
First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study gathers blood and leftover tissue samples from 200 people newly diagnosed with aggressive non-Hodgkin lymphoma, including types like diffuse large B-cell lymphoma and T-cell lymphoma. The samples are used to develop and validate blood-based tests that could monitor cancer and detect its return. Participants provide up to 60 mL of blood and allow use of tissue from standard procedures. The goal is to improve how lymphoma is tracked and managed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Blood and residual tissue sample collection for research (no drug or device)
- What this could lead to
- If successful, this could lead to better blood tests for monitoring and detecting non-Hodgkin lymphoma, potentially improving how the disease is tracked and managed.
- What could go wrong
- This is an early-stage sample collection study, not a treatment trial. The tests developed may not prove accurate or useful in clinical practice, and results are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAPLASTIC LARGE CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Natera, Inc.
RECRUITINGAustin, Texas, 78753, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells plus a checkpoint drug outsmart lymphoma?
- Can an immune booster outsmart brain lymphoma?
- A shot at safer CAR t: early brain protection for lymphoma patients?
- Can a Triple-Drug combo wipe out Slow-Growing lymphomas?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Engineered immune cells take aim at Hard-to-Treat lymphomas